Reprogramming the genetic code at the transcriptional level: the key in cancer
14 Oct 2016
Researchers at IRB Barcelona and ICREA professors Raúl Méndez, Salvador Aznar Benitah and Eduard Batlle have co-headed the B·Debate. At the end of the event, they spoke to Gaceta Médica about the advances made in cancer epigenetics.
El Economista, Cuatro, Geriatricarea, among other media, have published articles about the award received by Manuel Serrano, head of the Cellular Plasticity and Disease Lab at IRB Barcelona, for his work "Tissue damage and senescence provide critical signals for cell reprogramming in vivo".
Sergi Ferrer-Salat, president of the Board of Trustees of the Ferrer Research Foundation, highlighted that the work done by IRB Barcelona scientist, Manuel Serrano, is helping to further our understanding of the relation between ageing and cancer and identify approaches to manipulate this relation to our advantage.
The blog Handy Recovery has published an article about the "Cancer Genome Interpreter" (CGI), an open platform designed to support the identification of tumour alterations that drive the disease and detect those that may be therapeutically actionable. Núria López-Bigas, leader of the Biomedical Genomics Laboratory at IRB Barcelona, is part of this initiative.